Oxford BioDynamics Plc
OXBOFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6391500
P/E Ratio—
52W High$0.0133
52W Low$0.0014
Oxford BioDynamics Plc (OXBOF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OXBOF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.09M | $0.64M | $0.51M | $0.15M | $0.34M |
| Cost of Revenue | $0.57M | $0.35M | $0.24M | $0.04M | $0.90M |
| Gross Profit | $0.52M | $0.29M | $0.27M | $0.12M | $0.34M |
| Gross Margin %(computed) | 47.67% | 45.44% | 52.16% | 75.32% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.61M | $0.81M | $0.79M | $0.55M | $0.91M |
| G&A Expenses | $4.01M | $4.48M | $3.41M | $2.45M | $1.85M |
| Total Operating Expenses | $11.60M | $13.18M | $10.43M | $8.72M | $7.85M |
| Operating Income | ($11.07M) | ($12.89M) | ($10.17M) | ($8.60M) | ($7.51M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.06M | $0.11M | $0.07M | $0.01M | $0.03M |
| Interest Expense | $0.42M | $0.23M | $0.21M | $0.20M | $0.11M |
| Income Before Tax | ($11.42M) | ($11.96M) | ($11.41M) | ($7.57M) | ($7.63M) |
| Income Tax Expense | ($0.27M) | ($0.39M) | ($0.58M) | ($0.86M) | ($0.95M) |
| Net Income | ($11.15M) | ($11.57M) | ($10.83M) | ($6.71M) | ($6.68M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.04 | $-0.07 | $-0.07 | $-0.07 |
| Wtd Avg Shares | 1387.08M | 255.73M | 147.48M | 99.70M | 92.56M |
| EBITDA | ($9.80M) | ($10.27M) | ($9.84M) | ($6.77M) | ($6.43M) |
| EBITDA Margin %(computed) | -895.07% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · GBP · M
Explore more Oxford BioDynamics Plc data
About Oxford BioDynamics Plc (OXBOF) Income Statement
Oxford BioDynamics Plc (OXBOF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OXBOF reported revenue of $0.00B, gross profit of $0.00B (gross margin 47.67%), and net income of ($0.01B) — a net profit margin of -1018.54%.
Frequently asked questions
OXBOF · 4 questionsOxford BioDynamics Plc (OXBOF) reported revenue of $0.00B for 2025, up 72.2% year-over-year.
OXBOF revenueOXBOF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09